Multi-Year Registry Study of Elapegademase-lvlr Treatment in Patients with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy (ERT)
Document Type
Conference Proceeding
Publication Date
4-23-2024
Publication Title
Clinical Immunology
Abstract
2024 Clinical Immunology Society Annual Meeting: Immune Deficiency and Dysregulation North American Conference, May 1 - 4, 2024, Minneapolis, MN
Volume
262
Issue
Supplement
Recommended Citation
Dorsey, Morna; Butte, Manish; Lieberman, Jay; Lehman, Heather; Fausnight, Tracy; Keller, Michael; Fradette, Caroline; Hershfield, Michael; Pozos, Tamara; Rozova, Anna; Wall, Luke; de la Morena, M. Teresa; Bednarski, Jeffrey; Tarrant, Teresa; Chong, Hey; Geng, Bob; Temin, Noemi Toiber; Laubach, Susan; Lin, Leo; Mousallem, Talal; and Walter, Jolan, "Multi-Year Registry Study of Elapegademase-lvlr Treatment in Patients with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy (ERT)" (2024). School of Medicine Faculty Publications. 2904.
https://digitalscholar.lsuhsc.edu/som_facpubs/2904
10.1016/j.clim.2024.109962
Comments
Abstract Number 20